Cannabinoid Tolerance: Kinase Involvement Does Not Identify the Direct Receptor Target
Evidence that protein kinases participate in cannabinoid tolerance does not identify whether they act directly on CB1 receptors. A 2004 review explicitly left open the alternative that they contribute by modifying other signaling pathways.
Adaptation was observed at more than one level
Martin and colleagues described tolerance after repeated cannabinoid agonist exposure alongside CB1 downregulation and reduced G-protein activation. Receptor abundance and receptor-linked signaling are distinct observations. Their association with repeated exposure does not, by itself, identify a complete chain of causation from a particular kinase to a behavioral response.
A kinase effect can fit competing mechanisms
The review considered evidence implicating several protein kinases in tolerance development. It nevertheless distinguished direct CB1 regulation from modulation of additional pathways. A manipulation that changes a tolerance-related outcome may be consistent with either explanation. Demonstrating the exact molecular target requires evidence beyond simply observing that the manipulation changed behavior or signaling.
The mechanistic claim should match the experiment
If an experiment measures receptor-linked G-protein activity, the conclusion concerns that signaling assay. If it measures a repeated-dose behavioral response, the conclusion concerns that response. Linking the two is a further mechanistic step. This distinction is especially useful when a paper's findings are summarized as proof that a particular enzyme causes all cannabis tolerance.
Interpreting the evidence
The source is a historical mechanistic review, not a human test of an anti-tolerance treatment. Its unresolved question should not be presented as settled by the abstract. Kinase participation supports a pathway hypothesis; it does not establish a universal treatment target or an individual's degree of functional tolerance.
Related reading: the evidence gap in human CB1 desensitization imaging.
Research reference
Martin BR; Sim-Selley LJ; Selley DE (2004). Signaling pathways involved in the development of cannabinoid tolerance. Trends in pharmacological sciences. doi:10.1016/j.tips.2004.04.005. Evidence basis: review abstract.
